SE7513330L - Pseudotrisackarider och forfarande for framstellning derav - Google Patents
Pseudotrisackarider och forfarande for framstellning deravInfo
- Publication number
- SE7513330L SE7513330L SE7513330A SE7513330A SE7513330L SE 7513330 L SE7513330 L SE 7513330L SE 7513330 A SE7513330 A SE 7513330A SE 7513330 A SE7513330 A SE 7513330A SE 7513330 L SE7513330 L SE 7513330L
- Authority
- SE
- Sweden
- Prior art keywords
- gentamicin
- antibiotic
- deoxystreptamines
- aminoglycosyl
- kanamycin
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 abstract 3
- DNYGXMICFMACRA-UHFFFAOYSA-N gentamicin C1A Natural products O1C(CNC)CCC(N)C1OC1C(O)C(OC2C(C(NC)C(C)(O)CO2)O)C(N)CC1N DNYGXMICFMACRA-UHFFFAOYSA-N 0.000 abstract 3
- LKKVGKXCMYHKSL-LLZRLKDCSA-N gentamycin A Chemical compound O[C@H]1[C@H](NC)[C@@H](O)CO[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)N)[C@@H](N)C[C@H]1N LKKVGKXCMYHKSL-LLZRLKDCSA-N 0.000 abstract 2
- CEAZRRDELHUEMR-CAMVTXANSA-N (2r,3r,4r,5r)-2-[(1s,2s,3r,4s,6r)-4,6-diamino-3-[(2r,3r,6s)-3-amino-6-[(1r)-1-(methylamino)ethyl]oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol Chemical compound O1[C@H]([C@@H](C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-CAMVTXANSA-N 0.000 abstract 1
- XUFIWSHGXVLULG-BSBKYKEKSA-N (2r,3r,4r,5r)-2-[(1s,2s,3r,4s,6r)-4,6-diamino-3-[(2r,3r,6s)-3-amino-6-[(1s)-1-aminoethyl]oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol Chemical compound O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H](CC[C@H](O2)[C@H](C)N)N)[C@@H](N)C[C@H]1N XUFIWSHGXVLULG-BSBKYKEKSA-N 0.000 abstract 1
- BRZYSWJRSDMWLG-DJWUNRQOSA-N (2r,3r,4r,5r)-2-[(1s,2s,3r,4s,6r)-4,6-diamino-3-[(2s,3r,4r,5s,6r)-3-amino-4,5-dihydroxy-6-[(1r)-1-hydroxyethyl]oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol Chemical compound O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H]([C@@H](C)O)O2)N)[C@@H](N)C[C@H]1N BRZYSWJRSDMWLG-DJWUNRQOSA-N 0.000 abstract 1
- XUSXOPRDIDWMFO-CTMSJIKGSA-N (2r,3r,4r,5r)-2-[(1s,2s,3r,4s,6r)-4,6-diamino-3-[[(2s,3r)-3-amino-6-[(1s)-1-aminoethyl]-3,4-dihydro-2h-pyran-2-yl]oxy]-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol Chemical compound O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H](CC=C(O2)[C@H](C)N)N)[C@@H](N)C[C@H]1N XUSXOPRDIDWMFO-CTMSJIKGSA-N 0.000 abstract 1
- ABCLPPNEPBAKRL-ROQIPNNMSA-N (2r,3s,4s,5r,6s)-2-[(1r)-1-aminoethyl]-6-[(1r,2r,3s,4r,6s)-4,6-diamino-3-[(2r,3r,4r,5r)-3,5-dihydroxy-5-methyl-4-(methylamino)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxyoxane-3,4,5-triol Chemical compound O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H]([C@@H](C)N)O2)O)[C@@H](N)C[C@H]1N ABCLPPNEPBAKRL-ROQIPNNMSA-N 0.000 abstract 1
- DAKDDLIZULPEFW-UHFFFAOYSA-N 2-[4,6-diamino-3-[[3-amino-6-(aminomethyl)-3,4-dihydro-2h-pyran-2-yl]oxy]-2-hydroxycyclohexyl]oxy-4-(methylamino)oxane-3,5-diol Chemical compound OC1C(NC)C(O)COC1OC1C(O)C(OC2C(CC=C(CN)O2)N)C(N)CC1N DAKDDLIZULPEFW-UHFFFAOYSA-N 0.000 abstract 1
- VIAXDDBFFSKHGA-UHFFFAOYSA-N Antibiotic G52 Natural products CNC1CC(N)C(OC2OCC(C)(O)C(NC)C2O)C(O)C1OC3OC(=CCC3N)CN VIAXDDBFFSKHGA-UHFFFAOYSA-N 0.000 abstract 1
- YQGZDAPJXRYYLX-ZFAMMYHGSA-N Antibiotic JI-20A Chemical compound O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CN)O2)N)[C@@H](N)C[C@H]1N YQGZDAPJXRYYLX-ZFAMMYHGSA-N 0.000 abstract 1
- WYJSPPYVEJPMJA-DJWUNRQOSA-N Antibiotic JI-20B Chemical compound O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H]([C@@H](C)N)O2)N)[C@@H](N)C[C@H]1N WYJSPPYVEJPMJA-DJWUNRQOSA-N 0.000 abstract 1
- DNYGXMICFMACRA-XHEDQWPISA-N Gentamicin C2b Chemical compound O1[C@H](CNC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N DNYGXMICFMACRA-XHEDQWPISA-N 0.000 abstract 1
- HFLKNINDVFJPQT-UHFFFAOYSA-N Gentamicin X2 Natural products O1CC(O)(C)C(NC)C(O)C1OC1C(O)C(OC2C(C(O)C(O)C(CO)O2)N)C(N)CC1N HFLKNINDVFJPQT-UHFFFAOYSA-N 0.000 abstract 1
- HFLKNINDVFJPQT-ZFAMMYHGSA-N Gentamicin X2 Chemical compound O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)N)[C@@H](N)C[C@H]1N HFLKNINDVFJPQT-ZFAMMYHGSA-N 0.000 abstract 1
- URWAJWIAIPFPJE-UHFFFAOYSA-N Rickamicin Natural products O1CC(O)(C)C(NC)C(O)C1OC1C(O)C(OC2C(CC=C(CN)O2)N)C(N)CC1N URWAJWIAIPFPJE-UHFFFAOYSA-N 0.000 abstract 1
- 229930192786 Sisomicin Natural products 0.000 abstract 1
- XUSXOPRDIDWMFO-UHFFFAOYSA-N Verdamicin Natural products O1CC(O)(C)C(NC)C(O)C1OC1C(O)C(OC2C(CC=C(O2)C(C)N)N)C(N)CC1N XUSXOPRDIDWMFO-UHFFFAOYSA-N 0.000 abstract 1
- ARCVBMPERJRMKB-UHFFFAOYSA-N antibiotic g-52 Chemical compound O1C(CNC)=CCC(N)C1OC1C(O)C(OC2C(C(NC)C(C)(O)CO2)O)C(N)CC1N ARCVBMPERJRMKB-UHFFFAOYSA-N 0.000 abstract 1
- -1 antigbiotic 66-40B Chemical compound 0.000 abstract 1
- 229960001192 bekanamycin Drugs 0.000 abstract 1
- RHRAMPXHWHSKQB-GGEUKFTFSA-N betamicin Chemical compound O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CN)O2)O)[C@@H](N)C[C@H]1N RHRAMPXHWHSKQB-GGEUKFTFSA-N 0.000 abstract 1
- 230000003115 biocidal effect Effects 0.000 abstract 1
- JJCQSGDBDPYCEO-XVZSLQNASA-N dibekacin Chemical compound O1[C@H](CN)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N JJCQSGDBDPYCEO-XVZSLQNASA-N 0.000 abstract 1
- RHRAMPXHWHSKQB-UHFFFAOYSA-N gentamicin B Natural products O1CC(O)(C)C(NC)C(O)C1OC1C(O)C(OC2C(C(O)C(O)C(CN)O2)O)C(N)CC1N RHRAMPXHWHSKQB-UHFFFAOYSA-N 0.000 abstract 1
- 229930076781 gentamycin C1 Natural products 0.000 abstract 1
- VEGXETMJINRLTH-BOZYPMBZSA-N gentamycin C1a Chemical compound O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H](CC[C@@H](CN)O2)N)[C@@H](N)C[C@H]1N VEGXETMJINRLTH-BOZYPMBZSA-N 0.000 abstract 1
- XUFIWSHGXVLULG-JYDJLPLMSA-N gentamycin C2 Chemical compound O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H](CC[C@H](O2)[C@@H](C)N)N)[C@@H](N)C[C@H]1N XUFIWSHGXVLULG-JYDJLPLMSA-N 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 229960000318 kanamycin Drugs 0.000 abstract 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 abstract 1
- 229930182823 kanamycin A Natural products 0.000 abstract 1
- 229930182824 kanamycin B Natural products 0.000 abstract 1
- SKKLOUVUUNMCJE-FQSMHNGLSA-N kanamycin B Chemical compound N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SKKLOUVUUNMCJE-FQSMHNGLSA-N 0.000 abstract 1
- 229960004744 micronomicin Drugs 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 229960005456 sisomicin Drugs 0.000 abstract 1
- URWAJWIAIPFPJE-YFMIWBNJSA-N sisomycin Chemical compound O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H](CC=C(CN)O2)N)[C@@H](N)C[C@H]1N URWAJWIAIPFPJE-YFMIWBNJSA-N 0.000 abstract 1
- 125000005207 tetraalkylammonium group Chemical group 0.000 abstract 1
- 229960000707 tobramycin Drugs 0.000 abstract 1
- NLVFBUXFDBBNBW-PBSUHMDJSA-N tobramycin Chemical compound N[C@@H]1C[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N NLVFBUXFDBBNBW-PBSUHMDJSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/22—Cyclohexane rings, substituted by nitrogen atoms
- C07H15/222—Cyclohexane rings substituted by at least two nitrogen atoms
- C07H15/226—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings
- C07H15/234—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings attached to non-adjacent ring carbon atoms of the cyclohexane rings, e.g. kanamycins, tobramycin, nebramycin, gentamicin A2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/22—Cyclohexane rings, substituted by nitrogen atoms
- C07H15/222—Cyclohexane rings substituted by at least two nitrogen atoms
- C07H15/226—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings
- C07H15/234—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings attached to non-adjacent ring carbon atoms of the cyclohexane rings, e.g. kanamycins, tobramycin, nebramycin, gentamicin A2
- C07H15/236—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings attached to non-adjacent ring carbon atoms of the cyclohexane rings, e.g. kanamycins, tobramycin, nebramycin, gentamicin A2 a saccharide radical being substituted by an alkylamino radical in position 3 and by two substituents different from hydrogen in position 4, e.g. gentamicin complex, sisomicin, verdamycin
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US52859274A | 1974-11-29 | 1974-11-29 | |
| US52859374A | 1974-11-29 | 1974-11-29 | |
| US05/611,289 US4000261A (en) | 1974-11-29 | 1975-09-08 | 5-epi-4,6-di-o-(aminoglycosyl)-2-deoxystreptamines, methods for their manufacture and intermediates useful therein, methods for their use as antibacterial agents and compositions useful therefor |
| US05/611,290 US4000262A (en) | 1974-11-29 | 1975-09-08 | 5-epi-amino and 5-epi-azido-4,6-di-o-(aminoglycosyl)-2,5-dideoxystreptamines 1-n-alkyl-5-epi-amino and 1-n-alkyl-5-epi-azido-4,6-di-o-(aminoglycosyl)-2,5-dideoxystreptamines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SE7513330L true SE7513330L (sv) | 1976-05-31 |
Family
ID=27504618
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE7513330A SE7513330L (sv) | 1974-11-29 | 1975-11-26 | Pseudotrisackarider och forfarande for framstellning derav |
Country Status (17)
| Country | Link |
|---|---|
| JP (1) | JPS52244A (OSRAM) |
| AR (1) | AR215848A1 (OSRAM) |
| CA (1) | CA1048020A (OSRAM) |
| CH (1) | CH618986A5 (OSRAM) |
| DE (1) | DE2552799A1 (OSRAM) |
| DK (1) | DK531375A (OSRAM) |
| ES (1) | ES442989A1 (OSRAM) |
| FI (1) | FI753318A7 (OSRAM) |
| FR (1) | FR2292482A1 (OSRAM) |
| GB (1) | GB1528930A (OSRAM) |
| GR (1) | GR58472B (OSRAM) |
| IE (1) | IE43126B1 (OSRAM) |
| IL (1) | IL48558A (OSRAM) |
| LU (1) | LU73887A1 (OSRAM) |
| NL (1) | NL7513737A (OSRAM) |
| NO (2) | NO142080C (OSRAM) |
| SE (1) | SE7513330L (OSRAM) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2832268A1 (de) * | 1978-07-22 | 1980-01-31 | Bayer Ag | Pseudotrisaccharide |
| DE2924659A1 (de) * | 1979-06-19 | 1981-01-22 | Bayer Ag | Pseudotrisaccharide, ihre herstellung und verwendung als arzneimittel |
| JPWO2005070945A1 (ja) * | 2004-01-21 | 2007-09-06 | 明治製菓株式会社 | メチシリン耐性黄色ブドウ球菌（ｍｒｓａ）に有効な新規アミノグリコシド系抗生物質 |
-
1975
- 1975-11-21 CH CH1516575A patent/CH618986A5/de not_active IP Right Cessation
- 1975-11-25 DK DK531375A patent/DK531375A/da not_active Application Discontinuation
- 1975-11-25 GR GR49450A patent/GR58472B/el unknown
- 1975-11-25 NO NO753969A patent/NO142080C/no unknown
- 1975-11-25 FI FI753318A patent/FI753318A7/fi not_active Application Discontinuation
- 1975-11-25 DE DE19752552799 patent/DE2552799A1/de not_active Withdrawn
- 1975-11-25 FR FR7535989A patent/FR2292482A1/fr active Granted
- 1975-11-25 GB GB48412/75A patent/GB1528930A/en not_active Expired
- 1975-11-25 JP JP50141053A patent/JPS52244A/ja active Pending
- 1975-11-25 NL NL7513737A patent/NL7513737A/xx not_active Application Discontinuation
- 1975-11-25 AR AR261334A patent/AR215848A1/es active
- 1975-11-26 IE IE2577/75A patent/IE43126B1/en unknown
- 1975-11-26 CA CA240,567A patent/CA1048020A/en not_active Expired
- 1975-11-26 SE SE7513330A patent/SE7513330L/xx not_active Application Discontinuation
- 1975-11-26 ES ES442989A patent/ES442989A1/es not_active Expired
- 1975-11-27 IL IL48558A patent/IL48558A/xx unknown
- 1975-11-27 LU LU73887A patent/LU73887A1/xx unknown
-
1979
- 1979-03-16 NO NO790908A patent/NO790908L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| LU73887A1 (OSRAM) | 1976-09-06 |
| DK531375A (da) | 1976-05-30 |
| IE43126L (en) | 1976-05-29 |
| NO753969L (OSRAM) | 1976-06-01 |
| NO142080B (no) | 1980-03-17 |
| IL48558A (en) | 1980-07-31 |
| IE43126B1 (en) | 1980-12-31 |
| CH618986A5 (en) | 1980-08-29 |
| NO790908L (no) | 1976-06-01 |
| AR215848A1 (es) | 1979-11-15 |
| NL7513737A (nl) | 1976-06-01 |
| CA1048020A (en) | 1979-02-06 |
| GR58472B (en) | 1977-10-14 |
| NO142080C (no) | 1980-06-25 |
| AU8698875A (en) | 1977-06-09 |
| FR2292482A1 (fr) | 1976-06-25 |
| GB1528930A (en) | 1978-10-18 |
| JPS52244A (en) | 1977-01-05 |
| IL48558A0 (en) | 1976-01-30 |
| FR2292482B1 (OSRAM) | 1981-12-31 |
| DE2552799A1 (de) | 1976-08-12 |
| ES442989A1 (es) | 1977-08-16 |
| FI753318A7 (OSRAM) | 1976-05-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATA191078A (de) | Verfahren zur herstellung von neuen n-substi- tuierten derivaten der 4,6-di(aminoglycosyl)-1, 3-diaminocyclitole sisomicin, verdamicin, tobramycin, der kanamycine, der gentamicine a, b, b, b1, c1, c1a, c2, c2a, c2b, x2, der anti- biotika g-418, 66-40 b, 66-40 d, ji-20 a, ji-20 a, ji-20 b und g-52 sowie deren 5-epi-, 5-epi-amino-5-desoxy- und 5-epiazido-5-desoxy- derivaten und der mutamicine 1,2,4,5 und 6 | |
| HK484A (en) | Process of selectively blocking amino groups | |
| FR2309234A1 (fr) | Glucosides antitumoraux et leur procede de preparation | |
| BE799031A (fr) | Procede de preparation de revetements en polyurethanes, | |
| GB1494129A (en) | Derivatives of diaminocyclitols and methods for their preparation | |
| ES426998A1 (es) | Procedimiento para la obtencion de aminoglicosidos de 2 - deoxi - estreptamina. | |
| IE36434L (en) | Gentamicin antibiotics. | |
| SE7513330L (sv) | Pseudotrisackarider och forfarande for framstellning derav | |
| CH608022A5 (en) | Process for the preparation of halogenated aminoglycoside antibiotics and the use thereof | |
| ES435598A1 (es) | Procedimiento para la obtencion de uretampolioles. | |
| BE853564A (fr) | Procede de preparation d'antibiotiques aminoglycosidiques | |
| ES548953A0 (es) | Procedimiento para preparar complejos bromados y yodados con actividad antibiotica a partir de cepas de micromonospora. | |
| SU378019A3 (OSRAM) | ||
| CA1016165A (en) | 3'-deoxy derivatives of neamine and its related aminoglycosidic antibiotics, and the production thereof | |
| IL42180A (en) | Water insoluble antibiotics and processes for the preparation thereof | |
| BE796076A (fr) | Procede de preparation d'isocyanates | |
| IE39553L (en) | Garamine and intermediates in its preparation | |
| IE38063L (en) | Antibiotic g-52 | |
| SE384691B (sv) | Framstellning av ett nytt antibiotikum g-418 samt ev. ett nytt antibiotikum verdamicin i och/eller de kenda gentamicin a resp. sisomicin genom odling av de hitills okenda micromonospora rhodorangea och m.m. | |
| SATO et al. | A NEW AMINOGLYCOSIDE ANTIBIOTIC COMPLEX-THE SELDOMYCINS II. ISOLATION, PHYSICOCHEMICAL AND CHROMATOGRAPHIC PROPERTIES | |
| FR2405266A1 (fr) | Nouveaux pseudotrisaccharides, et applications pharmaceutiques de ceux-ci | |
| FR2305190A1 (fr) | Nouveaux medicaments anti-bacteriens a base de pseudotrisaccharides et leur procede d'obtention | |
| JPS55329A (en) | Novel xk-62-4 derivative | |
| GB1523634A (en) | Aminoglycoside antibiotics and a process for their production | |
| GB1500218A (en) | Derivative of antibiotic xk-62-2 and method of production thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NAV | Patent application has lapsed |
Ref document number: 7513330-6 Format of ref document f/p: F |